Esperion Therapeutics, Inc.ESPRNASDAQ
Loading
Current Ratio Over TimeCompressed
Percentile Rank7
3Y CAGR-40.7%
5Y CAGR-31.4%
Year-over-Year Change
Current ratio (current assets / current liabilities)
3Y CAGR
-40.7%/yr
vs +4.8%/yr prior
5Y CAGR
-31.4%/yr
Recent deceleration
Acceleration
-45.5pp
Decelerating
Percentile
P7
Near historical low
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.56 | -59.3% |
| 2024 | 1.37 | +6.7% |
| 2023 | 1.29 | -51.8% |
| 2022 | 2.67 | -40.4% |
| 2021 | 4.48 | +22.0% |
| 2020 | 3.68 | +14.8% |
| 2019 | 3.20 | +44.5% |
| 2018 | 2.22 | -64.0% |
| 2017 | 6.15 | -55.1% |
| 2016 | 13.70 | - |